![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Manhattan Scientifics Unit Partners With University of Michigan to Develop Breast Cancer Diagnostic
Manhattan Scientifics Unit Partners With University of Michigan to Develop Breast Cancer Diagnostic
Manhattan Scientifics’ Senior Scientific unit is joining up with the University of Michigan Medical School to develop a diagnostic for breast cancer detection.
The company is seeking to apply its magnetic relaxometry technology as a sensitive in vivo method for detecting molecular targets associated with specific cancer phenotypes.
Financial terms of the agreement were not disclosed. — Michael Cipriano
Upcoming Events
-
21Oct